Marrone Bio Innovations Posts Wider Quarterly Loss

Marrone Bio Innovations, Inc., a provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, posted a wider third-quarter net loss as expenses rose; however, revenue rose 16% in the period.

The net loss was $8.5 million in the quarter, compared with a loss of $7.2 million a year earlier.

Financial Highlights

  • GAAP revenues grew 31% to $14.8 million for the first nine months of 2017, compared to $11.4 million in the same year-ago period. GAAP revenues increased 16% to $4.2 million in the third quarter of 2017, compared to $3.6 million in the third quarter of 2016.
  • Product shipments1 grew 36% to $15.2 million for the first nine months of 2017, compared to $11.2 million in the same year-ago period. Product shipments were $3.1 million in the third quarter of 2017, compared to $3.1 million in the third quarter of 2017.
  • Gross margin increased to 41.2% for the first nine months of 2017, compared to 30.6% in the same year-ago period. Gross margin increased significantly to 40.9% in the third quarter of 2017, compared to 31.4% in the third quarter of 2016.
  • In October 2017, the Company entered into an unsecured promissory note with an investor, enabling the funding of certain tranches at the lender’s sole discretion. To date, the Company has received $2.0 million in funding under the note.

“We experienced several noteworthy catalysts in the third quarter of 2017, such as completion of our Grandevo WDG granulation line, as well as receiving EPA registration for MBI-110, which is the seventh product we’ve commercialized in 11 years,” said Dr. Pam Marrone, CEO of MBI. “Despite these major events, unfavorable weather conditions reduced the number of expected sprays in several of our key markets. Historically, the third quarter produces the lowest sales of the year and is the most unpredictable, evidenced by hurricanes Irma and Maria which significantly impacted our sales in Florida and Puerto Rico. Fortunately, our portfolio approach to product development and marketing diversifies our revenue base and reduces the impact of any one variable on the success of the company as a whole, and allowed us to achieve above industry-average growth for the first nine months of 2017.

“We remain positive on the long-term outlook of our business and have made significant progress in penetrating the United States market and abroad. To that end, we have greatly expanded our reach in international markets through select partnerships with regionally significant firms such as ÉLÉPHANT VERT in North Africa, Kenya Biologics in Kenya and Tanzania. We have taken significant steps to increase product awareness in the substantial Central and South American market, such as sponsoring grower education events in Honduras and Chile, as well as successfully advancing field trials in Brazil, which have shown tremendous results to-date.

“We’ve also made an immense amount of progress on the R&D front and are near completing the development of our first generation bio-herbicide, MBI-014, which remains on track for EPA submission in the near-term. MBI-014 will address one of the largest needs of organic farming—controlling weeds—and we believe it will be the first new mode of action herbicide in 25 years. Also in the third quarter, on October 27, 2017, we received EPA registration for MBI-110—which we branded ‘Stargus™’, for specialty crops and ‘Amplitude™’ for row crops. To our knowledge, no other agricultural company has successfully commercialized 7 new agricultural products from 6 active ingredients in such a short amount of time.”

Dr. Marrone concluded: “These R&D advancements, paired with the considerable progress in advancing distribution and product awareness, are translating into greater market opportunities and enhanced potential to create shareholder value.”

Recent Operational Highlights

  • Realized exceptional results from field trials in Brazil for Regalia®, Grandevo®, Majestene®, and Venerate®. MBI now anticipates a clear path to completion of the registration process in the country, paving the way to commercial sales in the large Brazilian crop protection market.
  • Received EPA registration for MBI-110, branded “Stargus™” for specialty crops and “Amplitude™” for row crops. MBI plans to launch Stargus™ in the United States market in 2017.
  • Completed the development of MBI-014 (formerly 010), an organic bio-herbicide that is set for an EPA submission in the near-term.
  • Albaugh, a major row crop seed treatment provider, had a successful first season with the BioST seed treatment containing an MBI microorganism. Preliminary results are positive and point to substantial yield increases over the standards.
  • Developed a strategy and focus to address grower demand of MBI products within the cannabis market through the creation of smaller pack sizes, hiring a cannabis segment sales specialist and utilizing Amazon as a direct-to-consumer sales channel.
  • As part of MBI’s collaboration with Evogene, transgenic plants carrying MBI’s insecticidal genes were developed and one candidate showed promising results (100% kill) against cabbage looper. Additional tests are in progress.
  • Joined a pilot project with AgShift, a Santa Clara-based agriculture technology startup, to assess the impact of the use of biological pesticides on the quality of fresh produce.
  • Signed new distribution agreements in Africa with regionally significant firms such as ÉLÉPHANT VERT in North Africa and Kenya Biologics in Kenya and Tanzania.
  • Finalized a distribution agreement with a large water treatment company for Zequanox.
  • Currently in discussions with several food companies about how to best transition growers to organic and help their grower suppliers with specific pest and disease problems.
  • Sponsored educational symposia for growers in Honduras and Chile with prominent local organizations to spread awareness of modern agricultural production technologies, including the use of biopesticides and stimulants in specialty crops.
  • Completed construction of the Grandevo WDG granulation line at MBI’s Marrone Michigan Manufacturing facility. This is currently producing a second-generation formulation to allow MBI to meet anticipated demand for this innovative new formulation.
  • Discovered new methods to increase the potency of Majestene and Grandevo, driving notably higher gross margins and increasing the effective capacity of the Marrone Michigan Manufacturing facility.
Topics: ,

Biopesticides

Americas

Valent USA Launches Aveo EZ Nematicide

Aveo EZ is a biological seed protectant that colonizes the roots of the soybean plant to reduce nematode reproduction.

Biopesticides

Marrone Bio Innovations Receives EPA Approval for Novel Biofungicide

The product, which is the sixth one to be commercialized by MBI in 11 years, is based on a new strain of Bacillus amyloliquefaciens discovered by MBI.

Biopesticides

Stockton, Lidorr Build Biological Manufacturing Unit

This manufacturing unit was designed to provide STK with the necessary capacity to advance its growing pipeline of biopesticides, hybrids and other biocontrol formulations.

Africa/Middle East

Marrone Bio Innovations Signs Exclusive Distribution Agreement with Kenya Biologics Ltd. for Kenya and Tanzania

The agreement Includes Reysana™ (Regalia®), Grandevo®, Venerate® and Majestene®.

Biopesticides

Valent U.S.A. Launches Sustainable Solutions Business Unit

Valent U.S.A. LLC has launched its Sustainable Solutions Business Unit, a new division within the company that is completely dedicated

Africa/Middle East

Marrone Bio Innovations Signs Distribution Agreement in North Africa

ÉLÉPHANT VERT, which has 300 employees in five countries in Africa and Europe and develops and markets organic amendments, biofertilizers, biostimulants and 100% natural biopesticides made in four production units, will develop and market two of MBI's products in Morocco, Tunisia and Algeria:

Biopesticides

Bayer, Ginkgo Bioworks Join Forces for Sustainable Agriculture

Bayer and Ginkgo Bioworks will create a new company focused on the plant microbiome. Improving the microbes’ ability to make

Africa/Middle East

Africa Faces Annual $2bn-plus Maize Deficit if Fall Armyworm Poorly Managed

The Centre for Agriculture and Biosciences International (CABI) has confirmed that Fall Armyworm (FAW) has been reported in 28 African

Biopesticides

AgShift Launches Pilot Project with Marrone Bio Innovations to Assess Biopesticides

Marrone Bio Innovations, a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and

Americas

AgBiome’s Howler Fungicide Receives EPA Approval

The first product to be marketed by AgBiome Innovations and developed by AgBiome Inc., is a biological fungicide that is highly effective against fungal diseases common to high-value crops.

Asia

Stockton Signs Distribution Deal with Syngenta Australia

The agreement grants Syngenta the exclusive right to distribute STK’s Timorex Gold biofungicide for application in edible crops in Australia and New Zealand.

Americas

Vive Crop Protection in Partnership with SDTC

Vive Crop Protection is pleased to announce a new partnership with four biopesticide manufacturers to develop new and improved biopesticides, supported by Sustainable Development Technology Canada (SDTC).

Americas

Cutting Edge Conferences: Meister Media to Host Precision Agriculture and Biocontrols Events

Biological control products and precision agriculture are among the fastest growing and most promising areas of growth for the crop

Biopesticides

Vive Crop Protection Forms Biopesticide Partnership with SDTC

Vive Crop Protection has announced a new partnership with four biopesticide manufacturers to develop new and improved biopesticides, supported by

Shimon-Steinberg
Africa/Middle East

Communication Key in South African Biocontrols Industry

Communication. It’s essential to all parts of agriculture, and the biocontrols industry in South Africa is no exception. Which is

Biopesticides

Biological Crop Protection Attracting Interest

There has been a flurry of excitement surrounding biological crop protection over the last few years, according to Spencer Maughan

Africa/Middle East

Marrone Bio Innovations Ships First Products to Africa

MBI shipped its biofungicide, REYSANA, to Morocco for use by growers on tomatoes, grapes and cucurbits.

Biopesticides

SLIDESHOW: Biocontrols Africa

Biocontrols Africa explored how members of the value chain can use biological products to maximize their return on investment. More than 230

Biopesticides

Former DuPont President Named Senior Ag Advisor for Zero Gravity Solutions

Zero Gravity Solutions, Inc. (ZGSI), an agricultural biotechnology public company commercializing its technology derived from and designed for space with

Latest News

Agrichemicals

Seed Firms’ Changes Bring Uncertainty, Promises

The months ahead will reveal what these altered players will look like and how they’ll work with dealers and growers. They’ll also show where companies are focusing efforts in trait development and crop systems.

Agrichemicals

Herbicide Debates Move Into the Courtroom

Over the past month, two herbicides, glyphosate and dicamba, have ended up with lawsuits filed in a pair of states.

Americas

Valagro Launches Biostimulant in Brazil

After being launched in Spain, Egypt, Mexico and Italy, RETROSAL is being officially presented to the Brazilian market.

Agrichemicals

Arysta LifeScience Names New Head of Europe, Middle East & Africa

Arysta LifeScience has named Hildo Brilleman as the company’s CEO of its Europe, Middle East & Africa (EMEA) region, effective

Agrichemicals

Missouri Latest U.S. State to Set Dicamba Cut-off Date for 2018

Missouri Department of Agriculture 'takes proactive measures to reduce off-target crop injury during the 2018 growing season.'